AzTrials
AzTrials

Paralytic StrokeNHOPNCT00646347

A Pilot Study of Neuro Hand Orthosis Program In Stroke Upper Limb Rehabilitation

A study testing Conventional upper limb stroke rehabilitation and Neuro Hand Orthosis Program (NHOP) in people with Paralytic Stroke, run by St Luke's Hospital, Singapore at 1 site in Singapore.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The implementation of Neuro Hand Orthosis Upper Limb Program can significantly improve the severe stroke paralytic arm in subacute rehabilitation as compared with the use of conventional therapy. Read more about this study

Who is it for?
Ages 50 to 89 years
Conditions the study is for
Paralytic Stroke
What is being tested?
Conventional upper limb stroke rehabilitation and Neuro Hand Orthosis Program (NHOP)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSingapore
Study dates
Mar 2008to Jul 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 89 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Post stroke between one week to three months and medically stable
  • Right Hemiplegia with right hand dominant
  • Able to stand with minimum assistance
  • AMT score not lesser then 7/10
  • Motricity Index Arm Score <36/100

Who cannot join

  • Unable to commit to the Neuro Hand Orthosis Program (either as in or out patients) for 10 weeks according to the program regime or unable to follow the control group regime for 10 weeks
  • Pre-existence shoulder or upper limb pain
  • Pre-existence moderate or severe hand oedema
  • Patients with terminal disease
  • Resident of Institution (eg, Nursing home etc prior to admission)
  • Pre-existing upper limb disability on affected arm
  • Psychiatric problem

Trial locations and contacts

1 site in 1 country.

Gribson Yu Chun Chan, Master contact

65632281 ext. 273

gribsonchan@slh.org.sg

Singapore1 site, 1 recruiting
  • St Luke's Hospital (Singapore)

    Singapore, 2 Bukit Batok, Street11, 659674

    Gribson Chan Yu Chun, Master, 689532281 ext. 237, gribsonchan@slh.org.sg

    Gribson Chan Yu Chun, Master

    Recruiting

Other trials in Singapore

About this study

Official title: A Pilot Study of Neuro Hand Orthosis Program: A Promising Restorative Therapy Treatment for the Severe Paralytic Arm in Subacute Stroke Rehabilitation

The implementation of Neuro Hand Orthosis Upper Limb Program can significantly improve the severe stroke paralytic arm in subacute rehabilitation as compared with the use of conventional therapy.

Read the detailed description

The neuro hand orthosis is based on a design of dynamic hand orthosis for orthopaedic patients. We attempt to apply such an orthosis on stroke patients to aid in regaining movement from severe paralytic arm by helping the patients to support their wrist and finger in a functional position for grasping. The patient is then encouraged to produce voluntary movement from the severe paralytic arm to transport an object (ball) from place to place either in sitting or standing position.

Since intensive arm usage is associated with neuro reorganisation, we propose designing a program with the neuro hand to encourage usage of the paralysed hand and help overcome the barriers of poor motivation and lack of arm usage through self practice program.

Being tested
Conventional upper limb stroke rehabilitation, Neuro Hand Orthosis Program (NHOP)
Keywords
stroke, upper limb rehabilitation, treatment, movement recovery from sever paralytic upper limb, neuro hand orthosis, self practice program, subacute
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional upper limb stroke rehabilitationOther

    Patient will be given a ten weeks conventional upper limb therapy. 3 sessions will be provided weekly in the first 4 weeks and 2 therapy sessions will be provided weekly in the subsequent 6 weeks. Patients will receive half an hour of conventional therapy in each session.

    Patient will be taught to carry out two and half hours conventional self practice exercise daily for a period of ten weeks.

  • Neuro Hand Orthosis Program (NHOP)Device

    The NHO is based on a design of dynamic hand orthosis for orthopaedic patients after hand surgery. We use it to support CVA patient's wrist and finger to perform grasping to transport an object (ball) from place to place to achieve the follows;

    1. NHO can assist stroke patients to experience successful hand grasping with an object and produce voluntary movement from their paralytic arm. This successful experience will positively reinforce the patient to continue to use their paralytic arm and change the patient's behavior and perception in the arm usage.
    2. The NHO Program is able to engage patients to perform their exercises and activities by themselves independently with the effect of intensive therapy.

    The intervention (NHOP) group will receive same treatment intensity as the control group but with a "Neuro Hand Orthosis".

Study groups in NCT00646347
Study groupRoleWhat they receive
AExperimentalConventional stroke upper limb rehabilitation is given
Receives: Other: Conventional upper limb stroke rehabilitation
BActive comparatorNeuro Hand Orthosis Program is given
Receives: Device: Neuro Hand Orthosis Program (NHOP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Action Research Arm Test (ARAT)

    Measured: week 4 , week 10 , 6 months and 12 months

  2. Motricity Index

    Measured: week 4 , week 10 , 6 months and 12 months

Secondary outcomes (3)
  1. Motor Activity Log (MAL)

    Measured: At admission, week 4 , week 10 , 6 months and 12 months

  2. Modified Ashworth Scale for grading Spasticity

    Measured: At admission, week 4 , week 10 , 6 months and 12 months

  3. Shoulder pain at admission

    Measured: At admission, week 4 , week 10 , 6 months and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2008 (estimated)
  2. Study startMar 2008
  3. Primary completionJan 2009 (estimated)
  4. Study completionJul 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00646347
Sponsor's protocol ID
slhdoc02
Acronym
NHOP
Status last verified
Feb 2009
First submitted
24 Mar 2008
Last updated
5 Feb 2009
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Conventional upper limb stroke rehabilitation and Neuro Hand Orthosis Program (NHOP) in people with Paralytic Stroke, run by St Luke's Hospital, Singapore at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Feb 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gribson Yu Chun Chan, Master (65632281 ext. 273, gribsonchan@slh.org.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Action Research Arm Test (ARAT) (time frame: week 4 , week 10 , 6 months and 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2009; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in